EMPAGLIFLOZIN - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2020-06-12
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:19:02
Label at a glance#
ProductEMPAGLIFLOZIN
Active ingredientEMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE
Products#
Every source-derived product name is available through these pages.
- EMPAGLIFLOZIN
- LINAGLIPTIN
- METFORMIN HYDROCHLORIDE
- METFORMIN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EMPAGLIFLOZIN | HDC1R2M35U | ACTIB |
| LINAGLIPTIN | 3X29ZEJ4R2 | ACTIB |
| METFORMIN HYDROCHLORIDE | 786Z46389E | ACTIB |
| EMPAGLIFLOZIN | HDC1R2M35U | ACTIB |
| LINAGLIPTIN | 3X29ZEJ4R2 | ACTIB |
| METFORMIN HYDROCHLORIDE | 786Z46389E | ACTIB |
| EMPAGLIFLOZIN | HDC1R2M35U | ACTIB |
| LINAGLIPTIN | 3X29ZEJ4R2 | ACTIB |
| METFORMIN HYDROCHLORIDE | 786Z46389E | ACTIB |
| EMPAGLIFLOZIN | HDC1R2M35U | ACTIB |
| LINAGLIPTIN | 3X29ZEJ4R2 | ACTIB |
| METFORMIN HYDROCHLORIDE | 786Z46389E | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jardiance | EMPAGLIFLOZIN | Redpharm Drug | 59ed43d9-b4e0-72a2-e063-6394a90a327d | 2026-08-26 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 334f1b3d-5670-6685-e063-6294a90a7e47 | 2026-06-17 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Cardinal Health 107, LLC | 5777b8a8-ada6-4950-8548-43a1de11f075 | 2026-02-17 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Boehringer Ingelheim Pharmaceuticals, Inc. | faf3dd6a-9cd0-39c2-0d2e-232cb3f67565 | 2026-01-30 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 8b6261f6-4bdc-462e-8af1-4064664c62f3 | 2025-10-27 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | A-S Medication Solutions | a77214ca-572e-485e-aae9-f7950187e5fb | 2023-08-08 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 942a82a4-cbbd-4e44-9965-8d03f767912b | 2023-07-24 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 1782b947-4a72-4feb-a488-1469d9af82bd | 2023-05-03 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | f2b41c77-0abb-40ee-8578-86a748d0e19e | 2023-05-03 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.